Annexon Biosciences CEO Doug Love considers Guillain-Barré syndrome — also known as GBS — to be the “most unique disease” he’s worked on in 25 years in biotech because of its sudden onset. A rare ...

Computer scientists, bioengineers and AI specialists from the Arc Institute and Stanford University have developed an AI-based model capable of decoding and designing genetic sequences.

Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that ...

Multiple sclerosis (MS) and Guillain-Barré syndrome (GBS) are diseases of the nervous system. They’re not the same, but they do have a lot of similarities. Both MS and GBS are autoimmune diseases.

MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained ...